How This Gene Therapy Got FDA Fast Track Status

Welcome back! In this week’s edition, explore the global momentum building around early-phase clinical trials in Medtech and Biopharma: A first-in-human knee implant trial expands from Poland to global FDA grants Fast Track designation to a gene therapy for Angelman syndrome Brazil’s orphan drug inc

first-in-human · gene therapy · FDA · MedTech · biopharma · rare disease

Welcome back! In this week’s edition, explore the global momentum building around early-phase clinical trials in Medtech and Biopharma:

A first-in-human knee implant trial expands from Poland to global FDA grants Fast Track designation to a gene therapy for Angelman syndrome Brazil’s orphan drug incentives open doors for rare disease innovators

Let’s get started! 👇

← All Global Trial Accelerators editions · Contact bioaccess®